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BACKGROUND:  Vitamin D is an important micronutrient 
impacting multiple physiologic functions including calcium, 
phosphorus and bone metabolism. Various studies demonstrate low 
vitamin D levels in non-specific neuromuscular pain disorders and 
chronic-fatigue-syndromes. This observation was supported by 
significant improvement of these disorders following Vitamin D 
supplementation. Several studies demonstrate low serum vitamin D 
levels in healthy adult Ethiopians despite availability of abundant 
sunlight. 
METHOD:  Retrospective medical records review of 62 patients 
presented to Yehuleshet Specialty Clinic between March 2014-
August 2015 with non-specific neuromuscular pain and fatigue. 
Serum vitamin D levels were obtained at initial clinic visit.   
RESULTS: The mean (±SD) age was 51.5 ±15.5 years. Two-third 
(69.4%) of the participants were female. The majority (56.5%) 
presented with mixed symptoms, including generalized body ache, 
paresthesia, neck and back pain, while 45.2% reported fatigue. 
Fifteen (24.2%) participants were on antiepileptic drugs. All 
patients had initial serum vitamin D levels < 30 ng/ml, among these 
62.9% demonstrated severe deficiency (< 12 ng/ml). Thirty (48.4%) 
participants reported symptomatic improvement after treatment 
with standard doses of vitamin D and calcium. Age > 50 years, 
being housewife, use of antiepileptic medications (AEDs), and 
higher serum parathyroid hormone are associated with severe 
vitamin D deficiency. 
CONCLUSION: This study demonstrated high prevalence of 
vitamin D deficiency among patients with non-specific 
neuromuscular pain and fatigue. Vitamin D replacement resulted 
in significant clinical improvement. It is important to screen 
vitamin D in individuals with limited sunlight exposure and 
patients on AEDs when presenting with neuromuscular pain and 
fatigue. 
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Vitamin D is a fat-soluble vitamin that promotes 
calcium and phosphorus absorption in the gut, 
thereby maintaining normal serum calcium and 
phosphate concentrations and enabling normal 
bone mineralization, bone growth, and remodeling. 
In addition to its role in calcium and bone 
homeostasis, vitamin D potentially regulates many 
other cellular functions. The vitamin D receptor 
(VDR) is nearly universally expressed in nucleated 
cells (1). Humans receive 80 – 90% of their 
vitamin D supply through ultraviolet B sunlight 
exposure of the skin and the rest through vitamin 
D-containing foods (2).  There are two forms of 
vitamin D: vitamin D2 or ergocalciferol (produced 
by plants) and vitamin D3 or cholecalciferol 
(produced by sunlight conversion of 7-
dehydrocholesterol in the skin) (3).  
Vitamin D deficiency may be attributed to 
inadequate sun exposure, dietary insufficiency, 
gastrectomy and gastric bypass surgery, pancreatic 
disease, liver disease, renal disease, and myriad 
causes of malabsorption including celiac disease, 
lactase deficiency, Crohn’s disease, parasitic 
infections and bacterial overgrowth.  In addition, 
neurologic disorders are the leading cause of long 
term disability globally (4).  These disorders 
include epilepsy, neuropathy, neoplastic diseases 
and neuroinfection necessitating the use of 
antiepileptic drugs (phenytoin, carbamazepine), 
antineoplastic and antiretroviral medications 
(cyclophosphamide and ritonavir, respectively), 
and antibiotics and anti-inflammatory agents 
(rifampicin, dexamethasone, respectively), all of 
which activate the pregnane-X receptor, up-
regulating the 24-hydroxylases, leading to 
increased degradation of vitamin D.  Indeed, 
anticonvulsant induced osteomalacia and related 
disorders are too common to be ignored. Vitamin D 
affects muscles strength, muscle bulk and 
neuromuscular performance (5). 
There have been increasing reports over the 
past decade implicating vitamin D in sarcopenia, a 
reduction in skeletal muscle mass and strength.  
Several trials point out that there is an association 
between the blood serum level of 25(OH) D and 
musculoskeletal pain as well as non–specific back 
pain (6,7). Vitamin D has an anti-inflammatory 
effect through regulation of interleukin, tumor 
necrosis factor, and the activity of macrophages 
(8), and reduces pain in diabetic polyneuropathy 
patients (9).  Thus, the supplementation of vitamin 
D might theoretically have a beneficial effect on 
inflammatory induced pain. The aim of this study 
is to determine the prevalence of hypovitaminosis 
D among patients who presented with non-specific 
pain and fatigue, because vitamin D deficiency is a 
common and easily treatable disease. 
 
MATERIALS AND METHODS 
 
This is a retrospective chart review of patients who 
initially presented with non-specific neuromuscular 
pain and fatigue to Yehuleshet Specialty Clinic, 
located in Addis Ababa, Ethiopia. All the 62 
patients presented to the clinic with the main 
complaints of: localized body pain (other than back 
and neck pain), generalized body ache, lower  back 
pain, generalized fatigue or tiredness, neck pain, 
joint pain, shoulder pain and paresthesia. Serum 
vitamin D levels were determined and included in 
the review. Structured questionnaires were used to 
collect socio-demographic, clinical and laboratory 
data.   
All patients were fully evaluated upon initial 
presentation and laboratory test included serum 
vitamin D levels. All the 62 patients were treated 
with standard treatment regimen of vitamin D 
deficiency: vitamin D3 50,000 IU orally once 
weekly for four weeks + Calcium 1200mg orally 
daily, then maintenance vitamin D3 1000 IU daily 
orally for three months (8) and appointed for a 
three months followup. Upon the second visit after 
three months, serum vitamin D was determined to 
look for any biochemical improvement and patients 
was evaluated for clinical improvement, and 
diagnosed as improved, no change, or lost to 
followup.  
Seasons in Ethiopia are categorized in to four: 
1) Kiremt (summer) which includes June, July and 
August, and often characterized by heavy rain falls 
in these three months; 2) Belg (autumn) which 
includes September, October and November- It is 
also harvest season-; 3) Bega (winter) which 
includes December, January and February-It is also 
dry season-; 4) Tseday (spring) includes March, 
April and May. Autumn season is characterized 
with occasional showers. May is the hottest month 
in Ethiopia (17).  
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The following references standards were used 
during analysis: Serum Vitamin D: Severe 
deficiency (< 12ng/ml), moderate deficiency (12- 
20 ng/ml), mild deficiency (20-30 ng/ml), and 
normal (> 30 ng/ml). Serum calcium: normal 
reference range (2.12-2.55mmol/L), ionized 
calcium: normal reference range (1.16-
1.32mmol/L), serum parathyroid hormone: normal 
reference range (10-65ng/L), serum phosphorus: 
normal reference range (2.5 – 4.5 mg/dl) (18). The 
statistical analysis was performed using SPSS 
version 25.0 computer program. Descriptive 





The mean (±SD) age was 51.5 ±15.5 years. Half of 
the study participants were aged above 50 years; 
only 4.8% of the patients were aged ≤ 29 years. 
Two-third (69.4%) of the participants were female. 
In the majority of the cases (58.1%), serum vitamin 
D was determined during spring: between March to 
May (Table 1). Thirty-six (58.1%) of the patients 
were from Addis Ababa, 11.3% were from 
Oromiya regional state, while one patient was from 
Israel, the second was from Saudi Arabia.  Twenty 
(32.3%) of the patients were housewives, 14.5% 
owned private business, and 9.7% were 
government employees (Table 1).  
 
Table 1: Distribution of demographic and clinical characteristics, Yehuleshet Specialty Clinic, 2014-2015. 
 Frequency Percent (%) 
 
Age  
Mean ±SD 51.5 ±15.5  
≤ 29 years 3 4.8 
30-49 years 28 45.2 
≥50 years 31 50.0 
Gender Male 19 30.6 
Female 43 69.4 






















Fatigue   
Summer 12 19.4 
Autumn 1 1.6 













Generalized body ache 
Localized body aches 
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In cross tabulation, analysis done between different 
degree of hypovitaminosis D and age category; 
moderate and severe vitamin D deficiency was 
observed in those individual aged 50 years and 
above. Housewives tended to have more severe 
vitamin D deficiency. That is, their serum vitamin 
D was found to be < 20 ng/ml. 
The most common presenting complaints were 
mixed symptoms (56.5%), including: generalized 
body ache, neck pain, back pain and paresthesia. 
Twenty-eight (45.2%) individuals reported fatigue 
in addition to non-specific pain. Lower back pain 
and neck pain were reported in 21% and 6.5%, 
respectively (Table 1).Twenty-two (35.5%) of the 
patients reported additional symptoms, other than 
the presenting symptoms (Figure 1). Headache and 
pain were the commonest additional symptoms 
patients reported. Excessive sweat, dizziness and 
gait abnormalities were additional symptoms that 
were reported (Figure 1).  Seventeen (27.4%) of the 
patients had diagnosis of radiculopathy, while 
Osteoporosis, Osteoarthritis, and peripheral 
neuropathy accounted for 12.9%, 12.9% and 
11.3%, respectively. Parkinson’s disease accounted 
for 8.1%, thyroid disorders accounted for 3.2% and 
Neurosyphilis accounted for 3.2% (Table 2). 
 Table 2: Frequency distribution of patient diagnoses, Yehuleshet Specialty Clinic, 2014-2015. 
 
















Osteoporosis 8 12.9 
Osteoarthritis 8 12.9 
Rheumatoid arthritis 2 3.2 
Radiculopathy 17 27.4 
Hypocalcaemia 3 4.8 
Ataxia 1 1.6 
Peripheral neuropathy 7 11.3 
Myopathy 1 1.6 
Trigeminal Neuralgia 1 1.6 
Thyroid disorders 2 3.2 
Parkinson’s disease 5 8.1 
Seizure disorders 2 3.2 






















¶ NMS: Nonspecific musculoskeletal; ¶ AED: Antiepileptic drugs 
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Figure 1: Bar graph showing distribution of additional symptoms patients reported 
 
Hypertension is the commonest comorbid disorder 
identified in our study participants, followed by 
Diabetes mellitus. Out of 62 patients, 2 were HIV+ 
patients on ART, presented with non-specific pain 
and fatigue (Figure 2). Out of 62 patients, fifteen 
(24.2%) were on different types of antiepileptic 
medications. The majority (8.1%) of them were on 
carbamazepine, 4.8% were on valproate, while 
3.2% of the patients were on phenytoin (Table 2). 
Those patients who were on antiepileptic 
medications tended to have more moderate to 
severe vitamin D deficiency, than mild deficiency 
states. Out of total 15 patients on antiepileptic 
medications, 12(80%) had moderate to severe 
vitamin D deficiency, while 2 had adequate serum 
vitamin D. 
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All of our study participants had initial serum 
vitamin D determined upon presentation. Out of 62 
patients, the majority (62.9%) had severe 
hypovitaminosis D (<12ng/ml). only 2 patients had 
mild deficiency (Table 3). Twenty-three (37%) of 
the patients had followup serum vitamin D 
determined. The majority of them attained 
adequate serum vitamin D level, while still 8.1% 
had moderate deficiency. Out of 48 individuals 
whose total calcium was determined 67.7% had 
normal total calcium level. Out of 14 patients 
whose serum parathyroid level was determined, 
16.1% had elevated parathyroid hormone level. Of 
these, two-third of the patients whose parathyroid 
hormone level was found to be high had moderate 
to severe vitamin deficiency (Table 3). Out 62 
patients, 17 had serum phosphorus determined; 
among these, 22.6% had normal serum level (Table 
3).  
Out of 62 patients, 11 were screened for HIV 
serology, and two of them were found to be 
positive. A total of 61.3% were screened for 
syphilis by using VDRL test, and 2 were positive. 
Hepatitis B virus, Hepatitis C virus and Antinuclear 
antibody screening was done, and positive results 
were seen in 3.2%, 1.6% and 1.6%, respectively. 
Out of 62 patients, half reported clinical 
improvement on their presenting symptoms (Figure 
3).







Figure 2: Bar graph showing frequency distribution of comorbid disorders 
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Table 3: Frequency of serum level of Vitamin D, Calcium, PTH and Phosphorus, Yehuleshet Specialty 
Clinic, 2014-2015 
 Frequency Percent (%) 
Initial Vitamin D Mild deficiency 2 3.2 
Moderate deficiency 21 33.9 
Severe deficiency 39 62.9 
 







Mild deficiency 3 4.8 
Moderate deficiency 5 8.1 
 







Low 6 9.7 









Low 2 3.2 









High 10 16.1 









Low 3 4.8 
Not determined 45 72.6 
¶ PTH: Parathyroid hormone  
 
 
Figure 3: Bar graph showing clinical outcome after three months treatment with vitamin D 
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All of our study participants (100%) had vitamin D 
deficiency, in which more than half of them had 
severe hypovitaminosis D (< 12ng/ml). Those 
individuals above the age of 50 years, housewives 
and those on antiepileptic medications tended to 
have a more severe vitamin D deficiency. More 
than half of our patients presented with mixed 
symptoms, including: generalized body ache, neck 
pain and back pain and paresthesia, while twenty-
eight (45.2%), reported fatigue on top of the non-
specific pain. This finding comports with a Swiss 
report in which all of the participants initially 
presented with musculoskeletal pain, pain localized 
in shoulders, ribs, lower back and thighs, and 
fatigue (10). A Minnesota study demonstrated that 
28% of patients presenting with persistent non-
specific musculoskeletal pain to a community 
health centre had severe hypovitaminosis D, which 
further emphasize the importance of this disorder 
(11).  
Knutsen et al (5) reported possible association 
between vitamin D deficiency and presences of 
headache disorders. These findings were consistent 
to findings from this review, in which most of the 
patients reported headache (Figure 1). These 
findings may lead to further studies addressing the 
possible association between headache disorders 
and D deficiency. This is particularly important, 
because migraine headache is associated with 
severe disability among Ethiopians (12). 
Radiculopathy, osteoporosis, and osteoarthritis 
were the top three most common diagnoses among 
the study participants. Our study indicated that 
hypovitaminosis D is prevalent among patients 
with comorbid disorders, such as hypertension and 
diabetes mellitus (13). One-fourth of our patients 
were on antiepileptic medication which is one of 
the risk factors for development of hypovitaminosis 
D (14). Feleke et al (15) reported that greater 
proportion of people in Ethiopia had vitamin D 
deficiency despite abundant sun availability. The 
authors also explained low vitamin D among 
Ethiopians, likely related to the dressing habit, as 
most people, especially women tend to cover most 
of their body parts. These findings were supported 
by our study findings, where females are the 
majority and they tend to have more severe 
hypovitaminosis D, which could be explained by 
the fact that they are mostly housewives and spend 
a significant amount of their time indoor. Vitamin 
D insufficiency appears to be common among 
several other populations, including: dark skinned, 
obese, hospitalized, institutionalized, and 
individuals who consistently use sun screens and 
wear protective clothes. These is because, 
high melanin level inhibits the production 
of vitamin D in the skin.  Sunscreen prevents 
sunburn by blocking UVB light. Therefore, 
sunscreen use lowers vitamin D levels. However, 
as a practical matter, very few people put on 
enough sunscreen to block all UVB light, or 
they use sunscreen irregularly, 
so sunscreen's effects on vitamin D might not be 
significant in our setup (15, 19). 
Serum total calcium was observed to be fairly 
well maintained in most of our patients, despite 
observed high prevalence of vitamin D deficiency. 
This observation may need further community 
based study to understand the community level of 
serum vitamin D and calcium among Ethiopians, as 
dietary habit could potentially affect this finding. In 
this review, elevated serum parathyroid hormone 
level was observed indicating, hypovitaminosis D 
maybe one cause of hyperparathyroidism. Those 
individuals who were aged above 50 years, patients 
on antiepileptic medications, housewives, and 
those having elevated serum parathyroid hormone 
were found to have more severe hypovitaminosis 
D. These indicate the need to screen those 
individuals at risk of developing vitamin D 
deficiency.   
Vitamin D and its activated form 1.25-
dihydroxyvitamin D have a complex role in 
immunological system; 1.25-dihydroxyvitamin D 
has an important modulator effect on T 
lymphocytes. One of the most important 
observations from this review is the fact that half of 
the patients showed clinical symptom improvement 
after standard dose vitamin D and calcium 
replacement at three months followup period. 
These findings are consistent with the finding by 
Malabanan et al. (16), in which patients with 
nonspecific chronic pain, muscle pain, fall and 
weakness reported decreases in 25% after vitamin 
D replacement. Sufficient sun exposure can 
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provide an adequate amount of vitamin D3, which 
is stored in body fat and released during the winter, 
when vitamin D3 cannot be produced (8). Exposure 
of arms and legs for 5 to 30 minutes between the 
hours of 10 a.m. and 3 p.m. twice a week is often 
adequate (8). In addition, diet should contain 
sufficient amounts of vitamin D.  After patients 
attain sufficient vitamin D serum level, they have 
to continue having adequate sun exposure and take 
diet that contains sufficient amount of vitamin D 
and calcium and vitamin D supplementation. 
According to recommendations from the Institute 
of Medicine, adequate daily intake of vitamin D is 
200 IU daily for children and adults up to age 50 
years. For adults’ age between 51 to 70 years of 
age, 400 IU daily, and 600 IU daily for adults age 
above 71 years. However, most experts agree that 
without adequate sun exposure, children and adults 
require approximately 800 to 1000 IU per day (8). 
Limitations of this study are, being retrospective 
review, absence of controlled group for 
comparison, and relatively high loss to followup 
cases. The latter may be explained by the fact that, 
some of the patients are from the regional cities 
and outside Ethiopia; therefore they failed to show 
up at third month followup. 
These results support screening of all patients 
presenting with non-specific neuromuscular pain, 
back pain, paresthesia and fatigue for 
hypovitaminosis D in Ethiopia, despite abundant 
sunshine throughout the year. These paradoxical 
findings are most likely attributable to inadequate 
sun exposure practice and change in life style 
where most people spend their working and living 
time under shades. In addition, their diet contains 
insufficient amounts of vitamin D3. This is the first 
study to be reported from Ethiopia, assessing the 
prevalence of vitamin D deficiency among patients 
who presented with non-specific neuromuscular 
pain and fatigue. It is vital to conduct large scale 
community based studies to ascertain the baseline 
serum vitamin D and calcium level among different 
Ethiopian populations, to further understand the 
exact causes of vitamin D deficiency, uncover 
additional manifestations of vitamin D deficiency, 
and  identify other comorbid disorders which could 
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